Martingale Asset Management L P Moderna, Inc. Transaction History

Martingale Asset Management L P

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$109.18 - $185.98 $1.34 Million - $2.27 Million	-12,228 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$65.74 - $169.86 $196,891 - $508,730	-2,995 Reduced 19.67%	12,228 $1.28 Million
Q3 2020 Nov 12, 2020	BUY	$54.34 - $94.85 $157,912 - $275,634	2,906 Added 23.59%	15,223 $1.08 Million
Q2 2020 Aug 10, 2020	BUY	$29.67 - $80.0 $365,445 - $985,360	12,317 New	12,317 $790,000

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.